Revenue: The sum of all revenue fields included for a company's operating activities.
Matinas Biopharma Holdings, Inc. (MTNB) Revenue data is not available for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
|
Revenue |
-- |
$-2.15M |
|
-- |
|
-- |
|
$1.58M |
|
$-1.58M |
|
$0.04M |
|
$-1.53M |
|
$-1.53M |
|
$-1.53M |
|
$-1.53M |
|
$-1.53M |
|
$-1.53M |
|
$-1.58M |
|
$-1.47M |
|
5.44M |
|
5.44M |
|
$-0.40 |
|
$-0.40 |
|
| Balance Sheet Financials | |
$5.65M |
|
$0.16M |
|
$4.04M |
|
$9.70M |
|
$1.50M |
|
$0.01M |
|
$1.74M |
|
$3.23M |
|
$6.46M |
|
$6.46M |
|
$6.46M |
|
5.90M |
|
| Cash Flow Statement Financials | |
$-5.50M |
|
$0.32M |
|
$3.33M |
|
$7.53M |
|
$5.68M |
|
$-1.85M |
|
$0.81M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.78 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.18M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-23.72% |
|
-23.72% |
|
-15.80% |
|
-23.67% |
|
$1.09 |
|
$-0.95 |
|
$-1.01 |
|